Actively Recruiting

Age: 18Years - 80Years
All Genders
Healthy Volunteers
NCT06626646

Vascular Regenerative Cell Exhaustion in Adults with Peripheral Artery Disease (PAD-VRCE)

Led by Canadian Medical and Surgical Knowledge Translation Research Group · Updated on 2024-10-04

40

Participants Needed

2

Research Sites

39 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

PAD-VRCE is an observational, cross-sectional, two arm study aimed at determining if the presence of peripheral artery disease (PAD) can influence the number of circulating regenerative cells in blood. From peripheral blood samples, circulating progenitor cell content will be assessed via flow cytometry and compared between individuals with PAD and individuals without PAD. Ultimately, this study plans to evaluate the relationship between PAD, vascular regenerative cell exhaustion and overall cardiovascular health.

CONDITIONS

Official Title

Vascular Regenerative Cell Exhaustion in Adults with Peripheral Artery Disease (PAD-VRCE)

Who Can Participate

Age: 18Years - 80Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults aged 18 to 80 years who meet either: clinically significant symptomatic PAD with ankle brachial index less than 0.85, or no history of PAD
  • Willing and able to provide written informed consent and comply with study procedures
Not Eligible

You will not qualify if you...

  • Unable or unwilling to provide written informed consent or peripheral blood sample
  • Life-threatening disease expected to cause death within two years
  • Any malignancy not considered cured (no recurrence for 5 years), except basal cell carcinoma of the skin
  • Uncontrolled hypertension
  • New York Heart Association Class IV heart failure
  • Active liver disease or dysfunction
  • Active kidney disease or dysfunction
  • History of hemorrhagic stroke or major bleeding disorder
  • White blood cell count of 15x10^9/L or higher
  • Active infectious disease requiring systemic antibiotics or antiviral agents
  • Known acquired immunodeficiency syndrome (e.g., HIV)
  • Use of oral steroids or other immunosuppressive agents
  • Treated autoimmune disorders

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

North York Diagnostic and Cardiac Centre

North York, Ontario, Canada, M6B1N6

Actively Recruiting

2

Diagnostic Assessment Centre

Scarborough Village, Ontario, Canada, M1S4N6

Actively Recruiting

Loading map...

Research Team

J

Jack Casey

CONTACT

A

Aishwarya Krishnaraj, BScH

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here